ACMA Ltd. Announces Proposed Share Placement to Raise S\$339,128
ACMA Ltd. Proposes Private Placement of Up to 8.48 Million New Shares at 29% Premium to Market
ACMA Ltd. (SGX: ACMA) has announced a significant capital raising exercise via a proposed placement of up to 8,478,199 new ordinary shares at S\$0.04 per share. This placement is expected to raise gross proceeds of approximately S\$339,128.
Key Points of the Proposed Placement
- Number of Shares: Up to 8,478,199 new ordinary shares to be issued.
- Issue Price: S\$0.04 per share, representing a premium of approximately 29% to the last traded volume weighted average price (VWAP) of S\$0.031 on 29 December 2025.
- Gross Proceeds: About S\$339,128; net proceeds after estimated expenses (S\$20,000) will be approximately S\$319,128.
- Purpose: All net proceeds are intended for general working capital, to strengthen liquidity and position the Group for market opportunities and conditions.
- Investors: The shares will be placed with four private investors: Cui Wenyan, Peng Zhen, He Yuanxiang, and Lu Shansong, all of whom have no existing shareholding, business relationship, or concert party status with the company.
- Percentage of Capital: The placement shares will represent approximately 20% of the current issued share capital and about 16.7% of the enlarged post-placement share capital.
- General Mandate: The issuance will be executed under the general share issue mandate approved at the last AGM, without the need for a separate shareholder meeting.
- No Change of Control: The placement will not result in any change of control over the company.
- Listing Application: The company will apply for the new shares to be listed and quoted on the Mainboard of the SGX-ST.
- No Placement Agent or Commission: The company has not appointed any placement agent, nor is any commission or introducer fee payable.
Detailed Breakdown of Placement Subscribers
| Placee |
No. of Placement Shares |
Consideration (S\$) |
% of Existing Share Capital |
% of Enlarged Share Capital |
| Cui Wenyan |
4,278,199 |
171,128 |
10.09% |
8.41% |
| Peng Zhen |
1,400,000 |
56,000 |
3.30% |
2.75% |
| He Yuanxiang |
1,400,000 |
56,000 |
3.30% |
2.75% |
| Lu Shansong |
1,400,000 |
56,000 |
3.30% |
2.75% |
Important Aspects for Shareholders
-
Share Dilution: The placement will dilute existing shareholders by approximately 16.7% on a post-placement basis.
-
Potential Share Price Impact: The significant premium to the last traded price could be interpreted as a vote of confidence in ACMA’s prospects, potentially supporting the share price in the short-term.
-
Financial Effects: While the capital raised strengthens the balance sheet, the NTA per share will decrease slightly from 4.51 cents to 4.39 cents due to the increase in share count. Earnings per share (EPS) will fall from 1.52 cents to 1.27 cents based on FY2024 figures, as profits are divided among more shares.
-
Completion Risks: The placement is subject to several conditions, including SGX-ST approval, the validity of the general mandate, and the absence of adverse market or regulatory events. There is no certainty the placement will complete as planned.
-
Investor Profile: All placees are private investors with investment experience in equity markets, and none are directors, substantial shareholders, or otherwise related parties.
-
No Change in Control: No single investor or group will gain control as a result of this placement.
-
Use of Proceeds Disclosure: The company has committed to provide regular updates on the use of proceeds through SGX announcements and in its financial statements.
Background on Subscribers
- Cui Wenyan: Private investor, ex-brand marketing consultant, invested in China, US, and Singapore-listed firms.
- Peng Zhen: Managing Director of a Shenzhen tech firm, experienced private equity investor.
- He Yuanxiang: Ex-aesthetic doctor, CEO of a Chinese life sciences/beauty company, private equity investor.
- Lu Shansong: Ex-finance director and technology entrepreneur, experienced equity investor.
Salient Terms and Risks
- If completion conditions are not met within 90 business days, or if there are adverse events (e.g., trading suspension, insolvency, regulatory changes), the placement can be terminated by the placees or the company.
- The shares will rank pari passu with existing shares except for dividends or distributions whose record date falls before the allotment date.
- Copies of the agreements are available for shareholder inspection at the company’s registered office for three months.
Director and Major Shareholder Interests
- No director or controlling shareholder (or their associates) has any interest in the placement or the placees, other than their existing shareholdings.
- Post-placement, major shareholders will see their percentage interests reduced due to the enlarged share capital, but none will lose control.
Cautionary Note to Investors
The company advises shareholders and potential investors to exercise caution when trading ACMA shares, as the placement is subject to conditions and there is no guarantee of completion. Further announcements will be made as developments occur.
Disclaimer: This article is for general informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. Investors should consult their own financial advisors and consider their own circumstances before making any investment decisions. The information presented is based on company announcements and may be subject to change or revision.
View Acma Historical chart here
